Shares of Crescita Therapeutics Inc. (TSE:CTX – Get Free Report) fell 2.3% during trading on Thursday . The company traded as low as C$0.43 and last traded at C$0.43. 4,515 shares changed hands during trading, a decline of 74% from the average session volume of 17,152 shares. The stock had previously closed at C$0.44.
Crescita Therapeutics Stock Performance
The company has a current ratio of 3.80, a quick ratio of 2.29 and a debt-to-equity ratio of 6.66. The stock has a market cap of C$8.40 million, a price-to-earnings ratio of -4.30 and a beta of 1.66. The firm’s 50-day moving average is C$0.42 and its two-hundred day moving average is C$0.47.
About Crescita Therapeutics
Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.
Read More
- Five stocks we like better than Crescita Therapeutics
- Business Services Stocks Investing
- MarketBeat Week in Review – 4/22 – 4/26
- What is the Dogs of the Dow Strategy? Overview and Examples
- 3 Stocks Leading the U.S. Agriculture Comeback
- Quiet Period Expirations Explained
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
